Skip to main content

MRI-Guided Adaptive Radiation Dose Escalation

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

  • RegistryNCT04808323
  • PhasePhase 1
  • StatusRecruiting
  • ConditionLocally Advanced Rectal Adenocarcinoma
  • SponsorMedical College of Wisconsin
How MRI-Guided Adaptive RT worksNCT048083231 min

What the film says

Read the transcript

This trial is for adults with locally advanced rectal cancer, stage one to three, with the goal of preserving the rectum.

The idea: give higher doses of radiation focused on the tumor, using MRI guided adaptive radiation therapy, where the plan is adjusted in real time on MRI. Capecitabine chemotherapy is given during radiation, then FOLFOX chemotherapy after. Three groups test rising doses.

The study looks at side effects and the maximum tolerated dose.

This phase 1 study plans 22 patients. At the Medical College of Wisconsin in Milwaukee, William Hall and Carrie Peterson lead it.

Public record; not medical advice.

Sources behind this film

  • ClinicalTrials.gov record NCT04808323

    Adults; locally advanced (Stage I-III) rectal adenocarcinoma; organ preservation; Higher-dose MRI-guided adaptive RT; capecitabine; FOLFOX after; cohorts A-C; Toxicity and MTD; Phase 1; 22; MCW; William Hall, Carrie Peterson

The drug

What is being tested.

After the completion of radiation, subjects will receive up to eight cycles of systemic chemotherapy. (FOLFIRINOX may be used at the discretion of the treating medical oncologists.)

Cohort A will receive 14 Gy boost for a total of 64 Gy over 32 total fractions.

Study Rationale: There are limited studies evaluating real-time adaptive radiation therapy for locally advanced (Stage I-III) rectal adenocarcinoma with the goal of accomplishing organ preservation. We are testing higher doses of radiation therapy, using a novel method of real-time adaptive MRI-based radiation therapy treatment.

The study

How the trial runs.

This study is a prospective, open-label, phase I design.

Live record on ClinicalTrials.gov →

Eligibility

Who the study is looking for.

  • Pathologically confirmed (histologic or cytological), adenocarcinoma of the rectum.
  • Determined on staging evaluation to be clinical stage I, II or III.
  • No concerning unequivocal or biopsy-proven metastatic disease. Patients are eligible with either no evidence of distant metastatic disease, or "equivocal" evidence of distant metastatic disease, as judged by the multidisciplinary tumor board. This "equivocal" definition can include small lung or liver lesions that are not able to be radiographically characterized otherwise.
  • Eastern Cooperative Oncology Group (ECOG) status 0-2 within 45 days of study entry.
  • History/physical examination, including collection of weight and vital signs within 45 days prior to start of treatment.
  • MR of the rectum is mandatory for staging and follow-up.

Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.

How these trials work: what Phase 1 actually is · common questions Not clinical evidence.